Mark N. Lampert

Companies

• IMMUNIC, INC.Board member Feb 27, 2026 to now¹
• Kymera TherapeuticsBoard member Jan 13, 2023 to now²
• Olema Pharmaceuticals, Inc.Board member Jun 14, 2022 to now³
• MoonLake ImmunotherapeuticsBoard member Apr 15, 2022 to now⁴
• Rain Oncology Inc.Board member Nov 10, 2022 to Jan 29, 2024⁵
• CTI BioPharmaBoard member Aug 11, 2022 to Jun 28, 2023⁶
• XOMA Royalty CorpBoard member May 20, 2022 to May 19, 2023⁷
• INFINITY PHARMACEUTICALS, INC.Board member Dec 2, 2016 to Jan 5, 2017⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKymera Therapeutics KYMR257,754 shares⁹$27.8M at $108.02Jun 20, 2023
• MIMoonLake Immunotherapeutics MLTX1,039,238 shares¹⁰$10.1M at $9.72Mar 31, 2026
• OPOlema Pharmaceuticals, Inc. OLMA447,526 shares¹¹$3.2M at $7.11Jun 23, 2026
• CTI BioPharma745,644 shares¹²Aug 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 31, 2026Sold 248,530 shares at $16.79 of MoonLake Immunotherapeutics¹⁰
• Mar 31, 2026Sold 1,569,116 shares at $16.79 of MoonLake Immunotherapeutics¹⁰
• Mar 31, 2026Sold 1,932,354 shares at $16.79 of MoonLake Immunotherapeutics¹⁰
• Aug 9, 2022Converted 1,519,999 shares of CTI BioPharma¹²
• Aug 9, 2022Sold 1,289,434 shares at $6.12 of CTI BioPharma¹²
• Aug 9, 2022Converted 682,666 shares of CTI BioPharma¹²
• Aug 9, 2022Sold 469,040 shares at $6.12 of CTI BioPharma¹²
• Aug 9, 2022Converted 2,426,666 shares of CTI BioPharma¹²
• Aug 9, 2022Sold 2,890,723 shares at $6.12 of CTI BioPharma¹²
• Aug 9, 2022Converted 3,754,000 shares of CTI BioPharma¹²
• Aug 9, 2022Sold 3,850,803 shares at $6.12 of CTI BioPharma¹²